Optimal patient selection for anticoagulant therapy in sepsis: an evidence-based proposal from Japan
Author:
Affiliation:
1. Division of Trauma and Surgical Critical Care; Osaka General Medical Center; Osaka Japan
2. Department of Traumatology and Acute Critical Medicine; Osaka University Graduate School of Medicine; Osaka Japan
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13946/fullpdf
Reference13 articles.
1. Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis;Allingstrup;Intensive Care Med,2016
2. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016;Rhodes;Intensive Care Med,2017
3. Should all septic patients be given systemic anticoagulation? No;Poll;Intensive Care Med,2017
4. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety;Wiedermann;Crit Care Med,2006
5. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation;Kienast;J Thromb Haemost,2006
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy: An observational study;Thrombosis Research;2024-09
2. Practical approach to thrombocytopenia in patients with sepsis: a narrative review;Thrombosis Journal;2024-07-22
3. Fibrinaloid Microclots and Atrial Fibrillation;Biomedicines;2024-04-17
4. Exploring the Mediating Role of Multiple Organ Dysfunction in Sepsis-Induced Disseminated Intravascular Coagulation and Its Impact on Worsening Prognosis;Clinical and Applied Thrombosis/Hemostasis;2024-01
5. Sepsis-induced coagulopathy (SIC) score is an independent predictor of mortality and overt-disseminated intravascular coagulation in emergency department patients with sepsis;Signa Vitae;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3